Work

Cytokine-informed single-cell and bulk transcriptomics refine risk stratification and identify TBX19 as a prioritized candidate in colorectal cancer

Year: 2026
Type: article
Abstract: Immune checkpoint blockade (ICB) has improved the treatment of mismatch repair-deficient (dMMR) and microsatellite instability-high (MSI-H) colorectal cancer (CRC), but the tumor-cell programs that link response, cytokine signaling, and clinical outcome remain incompletely defined. We integrated a single-cell anti-programmed death 1 (PD-1) CRC cohort with bulk transcriptomic datasets to derive a cytokine-related immunotherapy response-associated gene set (CIBG) from response-associated signals and cytokine-pathway genes. The 39-gene signature was higher in non-responders and showed potential survival associations and immune remodeling in bulk CRC cohorts. In malignant epithelial cells, high CIBG activity marked an inflammatory state with NF-κB/TNF-α pathway activity, chemokine signaling, cytokine-response programs, and altered tumor functional scores. Inferred secreted-signaling analysis linked CIBG-high malignant cells with CXCL-, GDF-, and ANNEXIN-related interactions involving endothelial, fibroblast, and myeloid compartments. Projection of CIBG-high malignant cell genes into bulk tumors resolved two molecular subtypes with distinct clinical and transcriptional features and potential survival associations, consensus molecular subtype composition, immune-response prediction, checkpoint expression, pathway activity, and tumor microenvironment structure. Within the subtype with poorer outcome, TBX19 showed the most consistent risk association across survival analyses. TBX19 was increased in tumor tissues and differed across pathological stages. It was associated with stromal and invasion-related transcriptional features. In SW480 and HCT116 cells, shRNA-mediated TBX19 knockdown reduced TBX19 mRNA and protein expression and reduced proliferation, migration, and wound closure. These data support a cytokine-informed transcriptomic approach to CRC stratification and identify TBX19 as a prioritized prognostic candidate.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235063281
FWCI:
Cites: 43
Cited by:
Related to: 10
Parts: 2